Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 22 (EEF1A1P22)

Target
EEF1A1P22
Molecular classification
Other (Pseudogene)
01

Overview

EEF1A1P22 is a **processed pseudogene** of the eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) gene. Pseudogenes like EEF1A1P22 arise from duplication or retrotransposition events and do not encode functional proteins. The EEF1A1 gene itself encodes a key factor in translation elongation by delivering aminoacylated tRNAs to the ribosome, but EEF1A1P22 does not produce this or any related protein. Its role, if any, in human biology remains primarily uncharacterized, with no evidence supporting it as a therapeutic target or as a direct biomarker in disease[1][3]. The function and disease relevance of most EEF1A1 pseudogenes, including EEF1A1P22, are currently unknown; they may potentially regulate their parental gene or participate in other non-protein-coding regulatory mechanisms, but this remains speculative and is not experimentally validated[1][3].

Other names
EEF1A1P22
02

Biological functions

Other (No confirmed protein product; pseudogene)
03

Disease associations

Other (No direct disease association known)

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 22 (EEF1A1P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 22 (EEF1A1P22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call